Damier et al. (1993) described no differences in GFAP staining in different brain areas of control and PD patients, while Thannickal et al. (2007) observed increasing levels of GFAP with PD’s progression in the hypothalamus of PD cases compared to controls. Here, GFAP is linked to Parkinson disease.